Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00407160 · ClinicalTrials.gov registry record

A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
21
Enrollment target

NCT00407160 is a clinical trial that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00407160 has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
21 participants
Enrollment target

Study Summary

Comparison between Campath induction and monotherapy with Tacrolimus vs Thymoglobulin induction and triple drug maintenance using Tacrolimus, mycophenolate, and steroids.

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2004-08
Est. Completion 2011-01

What the Registry Record Tells You About NCT00407160

The ClinicalTrials.gov registry entry for NCT00407160 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00407160 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00407160 about?

NCT00407160 is a clinical study titled "A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients". Comparison between Campath induction and monotherapy with Tacrolimus vs Thymoglobulin induction and triple drug maintenance using Tacrolimus, mycophenolate, and steroids.

What is the current status of trial NCT00407160?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2004-08. Estimated completion is 2011-01.

Who is sponsoring clinical trial NCT00407160?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.